Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01198509 · ClinicalTrials.gov registry record · NA
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
NCT01198509 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 178 participants.
The verdict
NCT01198509, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
Study Summary
Rheumatoid arthritis (RA) is an inflammatory form of arthritis that causes joint pain and damage. RA attacks the lining of the joints (synovium), causing swelling that can result in aching and throbbing, and eventually deformity. Even though there have been many advances in the treatment of RA, psoriatic arthritis (PsA), and other inflammatory arthritis, doctors still do not know what causes this inflammation in joints. It is likely that RA occurs as a result of a complex combination of factors, including a person's genes; lifestyle choices, such as smoking and diet; and things in a person's environment, including bacteria or viruses. This study investigates the hypothesis that bacteria living in a person's mouth and/or intestinal tract are responsible, at least in part, for the development of Rheumatoid Arthritis. The investigators believe that by killing those bacteria with antibiotics, they might be able to understand how the immune system works and, maybe, what causes RA.
Interventions
- DRUG doxycycline
- DRUG vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01198509
The ClinicalTrials.gov registry entry for NCT01198509 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which doxycycline is the first listed.
NCT01198509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01198509 about?
NCT01198509 is a clinical study titled "Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)". Rheumatoid arthritis (RA) is an inflammatory form of arthritis that causes joint pain and damage. RA attacks the lining of the joints (synovium), causing swelling that can result in aching and throbbing, and eventually deformity. Even though there have been many advances in the treatment of RA, psor...
What is the current status of trial NCT01198509?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2010-01. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01198509?
The interventions under investigation include: doxycycline (DRUG), vancomycin (DRUG).
Who is sponsoring clinical trial NCT01198509?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.